SCHEMBL4259612

SCHEMBL4259612

CC(=O)Oc1cc(OC(C)=O)c2c(=O)cc(-c3ccc(O)c(OC(C)=O)c3)oc2c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.82
KDM4E B2RXH2 2/20 0.82
CYP3A4 P08684 2/20 0.82
HSD17B10 Q99714 2/20 0.82
MEN1 O00255 2/20 0.82
KMT2A Q03164 2/20 0.82
ALOX12 P18054 1/20 0.82
MAPK1 P28482 1/20 0.82
CASP1 P29466 1/20 0.82
CASP7 P55210 1/20 0.82
ALDH1A1 P00352 2/20 0.73
HPGD P15428 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
CYP1A1 P04798 1/20 0.56
CYP1A2 P05177 1/20 0.56
POLB P06746 1/20 0.56
ABCC1 P33527 1/20 0.56
CYP1B1 Q16678 1/20 0.56
HSD17B2 P37059 1/20 0.54
TAS2R31 P59538 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6725835 0.90 KDM4E (1.00) MAPTKDM4ECYP3A4HSD17B10MEN1
Apigenin Triacetate SCHEMBL1676023 0.88 KDM4E (0.88) MAPTKDM4ECYP3A4HSD17B10MEN1
SCHEMBL4259893 0.86 MAPT (0.82) MAPTKDM4ECYP3A4HSD17B10MEN1
Acacetin Diacetate SCHEMBL10026579 0.84 CYP3A4 (1.00) MAPTKDM4ECYP3A4HSD17B10MEN1
Chrysin Diacetate SCHEMBL15263635 0.84 KDM4E (0.78) MAPTKDM4ECYP3A4HSD17B10MEN1
SCHEMBL27772065 0.83 POLH (0.76) MAPTKDM4ECYP3A4HSD17B10MEN1
SCHEMBL23395441 0.81 MAPT (0.68) MAPTKDM4ECYP3A4HSD17B10MEN1
SCHEMBL14098630 0.80 BCHE (0.71) MAPTKDM4ECYP3A4HSD17B10MEN1
SCHEMBL10471809 0.80 KDM4E (0.72) MAPTKDM4ECYP3A4HSD17B10MEN1
SCHEMBL7451659 0.78 CYP3A4 (0.69) MAPTKDM4ECYP3A4HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067908-B2 Polyphenolic bioprecursors RHODIA CHIMIE (FR) 2015-06-30 US disclosed
US-20090215881-A1 Polyphenolic Bioprecursors CHIMIE, Rhodia Chime (FR) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215881-A1 Polyphenolic Bioprecursors PPARG, PPARA, FABP4 MAPT 3375/4885KDM4E 1867/4885CYP3A4 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.